- Home
- IMNN vs WATT Comparison
IMNN vs WATT Comparison
Compare IMNN & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- WATT
- Stock Information
- Founded
- IMNN 1982
- WATT 2012
- Country
- IMNN United States
- WATT United States
- Employees
- IMNN N/A
- WATT N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- WATT Radio And Television Broadcasting And Communications Equipment
- Sector
- IMNN Health Care
- WATT Technology
- Exchange
- IMNN Nasdaq
- WATT Nasdaq
- Market Cap
- IMNN 12.1M
- WATT 10.6M
- IPO Year
- IMNN 1985
- WATT 2014
- Fundamental
- Price
- IMNN $5.75
- WATT $7.69
- Analyst Decision
- IMNN Buy
- WATT
- Analyst Count
- IMNN 2
- WATT 0
- Target Price
- IMNN $182.61
- WATT N/A
- AVG Volume (30 Days)
- IMNN 55.7K
- WATT 48.8K
- Earning Date
- IMNN 11-06-2025
- WATT 11-11-2025
- Dividend Yield
- IMNN N/A
- WATT N/A
- EPS Growth
- IMNN N/A
- WATT N/A
- EPS
- IMNN N/A
- WATT N/A
- Revenue
- IMNN N/A
- WATT $1,976,000.00
- Revenue This Year
- IMNN N/A
- WATT $1,028.91
- Revenue Next Year
- IMNN N/A
- WATT $117.65
- P/E Ratio
- IMNN N/A
- WATT N/A
- Revenue Growth
- IMNN N/A
- WATT 434.05
- 52 Week Low
- IMNN $4.83
- WATT $3.67
- 52 Week High
- IMNN $41.22
- WATT $81.00
- Technical
- Relative Strength Index (RSI)
- IMNN 36.86
- WATT 44.83
- Support Level
- IMNN $5.53
- WATT $6.61
- Resistance Level
- IMNN $5.89
- WATT $10.50
- Average True Range (ATR)
- IMNN 0.32
- WATT 0.92
- MACD
- IMNN 0.07
- WATT 0.16
- Stochastic Oscillator
- IMNN 23.81
- WATT 27.83
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.